Benefits and risks of combination therapy in hypertension

Hypertens Res. 2009 Sep;32(9):727-8. doi: 10.1038/hr.2009.103. Epub 2009 Jul 17.

Author

Affiliation

¹ Department of Cardiovascular and Renal Medicine, Saga University, Saga, Japan. node@cc.saga-u.ac.jp

PMID: 19609269
DOI: 10.1038/hr.2009.103

No abstract available

Publication types

Comment

MeSH terms

Angiotensin II Type 1 Receptor Blockers / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Antihypertensive Agents / therapeutic use*
Blood Pressure / drug effects
Diuretics / therapeutic use
Drug Therapy, Combination*
Guidelines as Topic
Humans
Hypertension / drug therapy*
Hypertension / physiopathology
Patient Compliance
Randomized Controlled Trials as Topic

Substances

Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Diuretics